OPTI — OptiBiotix Health Balance Sheet
0.000.00%
- £5.84m
- £4.85m
- £1.17m
Annual balance sheet for OptiBiotix Health, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 2.01 | 1.05 | 0.635 | 0.739 | 1.04 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.69 | 0.616 | 0.539 | 0.445 | 0.241 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 3.85 | 1.86 | 1.38 | 1.42 | 1.64 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 20.1 | 11.5 | 9.4 | 9.04 | 6.89 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.601 | 0.278 | 0.18 | 0.368 | 0.384 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 2.01 | 0.643 | 0.532 | 0.647 | 0.61 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 18.1 | 10.9 | 8.87 | 8.4 | 6.28 |
| Total Liabilities & Shareholders' Equity | 20.1 | 11.5 | 9.4 | 9.04 | 6.89 |
| Total Common Shares Outstanding |